Click for best price
Diabetes Treatment Market Size, Share 2023
| Market size in 2022 |
US$ 43620 million
|
Forecast Market size by 2029 |
US$ 55290 million
|
| Growth Rate |
CAGR of 3.4% |
Number of Pages |
61 Pages |
The global Diabetes Treatment market was valued at US$ 43620 million in 2022 and is projected to reach US$ 55290 million by 2029, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
This report aims to provide a comprehensive presentation of the global market for Diabetes Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Treatment. This report contains market size and forecasts of Diabetes Treatment in global, including the following market information:
- Global Diabetes Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
As living standards improve, an increasing obesity, the Diabetes Treatment has improved people's living habits, disease control effect, is becoming more and more important.
We surveyed the Diabetes Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Treatment Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Diabetes Treatment Market Segment Percentages, by Type, 2022 (%)
- Insulin
- Oral Hypoglycaemic Drugs
- Non-Insulin Injectable Drugs
Global Diabetes Treatment Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Diabetes Treatment Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Personal Use
- Clinic
- Others
Global Diabetes Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Diabetes Treatment Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Diabetes Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Diabetes Treatment revenues share in global market, 2022 (%)
Key players include:
- Novo Nordisk
- AstraZeneca
- Teva Pharmaceuticals
- MerckCompany
- Medtronic
- JohnsonJohnson
- Sanofi
- GlaxoSmithKline
- Abbott Laboratories
- Benemae
- Eli Lilly
- Boehringer Ingelheim
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Treatment, market overview.
Chapter 2: Global Diabetes Treatment market size in revenue.
Chapter 3: Detailed analysis of Diabetes Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Diabetes Treatment Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 43620 million
|
| Forecast Market size by 2029 |
US$ 55290 million
|
| Growth Rate |
CAGR of 3.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetes Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Treatment Overall Market Size
2.1 Global Diabetes Treatment Market Size: 2022 VS 2030
2.2 Global Diabetes Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Treatment Players in Global Market
3.2 Top Global Diabetes Treatment Companies Ranked by Revenue
3.3 Global Diabetes Treatment Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diabetes Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Treatment Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Treatment Market Size Markets, 2022 & 2030
4.1.2 Insulin
4.1.3 Oral Hypoglycaemic Drugs
4.1.4 Non-Insulin Injectable Drugs
4.2 By Type - Global Diabetes Treatment Revenue & Forecasts
4.2.1 By Type - Global Diabetes Treatment Revenue, 2018-2023
4.2.2 By Type - Global Diabetes Treatment Revenue, 2024-2030
4.2.3 By Type - Global Diabetes Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Treatment Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Personal Use
5.1.4 Clinic
5.1.5 Others
5.2 By Application - Global Diabetes Treatment Revenue & Forecasts
5.2.1 By Application - Global Diabetes Treatment Revenue, 2018-2023
5.2.2 By Application - Global Diabetes Treatment Revenue, 2024-2030
5.2.3 By Application - Global Diabetes Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Diabetes Treatment Market Size, 2022 & 2030
6.2 By Region - Global Diabetes Treatment Revenue & Forecasts
6.2.1 By Region - Global Diabetes Treatment Revenue, 2018-2023
6.2.2 By Region - Global Diabetes Treatment Revenue, 2024-2030
6.2.3 By Region - Global Diabetes Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Diabetes Treatment Revenue, 2018-2030
6.3.2 US Diabetes Treatment Market Size, 2018-2030
6.3.3 Canada Diabetes Treatment Market Size, 2018-2030
6.3.4 Mexico Diabetes Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Diabetes Treatment Revenue, 2018-2030
6.4.2 Germany Diabetes Treatment Market Size, 2018-2030
6.4.3 France Diabetes Treatment Market Size, 2018-2030
6.4.4 U.K. Diabetes Treatment Market Size, 2018-2030
6.4.5 Italy Diabetes Treatment Market Size, 2018-2030
6.4.6 Russia Diabetes Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Diabetes Treatment Market Size, 2018-2030
6.4.8 Benelux Diabetes Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Diabetes Treatment Revenue, 2018-2030
6.5.2 China Diabetes Treatment Market Size, 2018-2030
6.5.3 Japan Diabetes Treatment Market Size, 2018-2030
6.5.4 South Korea Diabetes Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Diabetes Treatment Market Size, 2018-2030
6.5.6 India Diabetes Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Diabetes Treatment Revenue, 2018-2030
6.6.2 Brazil Diabetes Treatment Market Size, 2018-2030
6.6.3 Argentina Diabetes Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Treatment Revenue, 2018-2030
6.7.2 Turkey Diabetes Treatment Market Size, 2018-2030
6.7.3 Israel Diabetes Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Diabetes Treatment Market Size, 2018-2030
6.7.5 UAE Diabetes Treatment Market Size, 2018-2030
7 Diabetes Treatment Companies Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Diabetes Treatment Major Product Offerings
7.1.4 Novo Nordisk Diabetes Treatment Revenue in Global Market (2018-2023)
7.1.5 Novo Nordisk Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Diabetes Treatment Major Product Offerings
7.2.4 AstraZeneca Diabetes Treatment Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Teva Pharmaceuticals
7.3.1 Teva Pharmaceuticals Company Summary
7.3.2 Teva Pharmaceuticals Business Overview
7.3.3 Teva Pharmaceuticals Diabetes Treatment Major Product Offerings
7.3.4 Teva Pharmaceuticals Diabetes Treatment Revenue in Global Market (2018-2023)
7.3.5 Teva Pharmaceuticals Key News & Latest Developments
7.4 Merck?Company
7.4.1 Merck?Company Company Summary
7.4.2 Merck?Company Business Overview
7.4.3 Merck?Company Diabetes Treatment Major Product Offerings
7.4.4 Merck?Company Diabetes Treatment Revenue in Global Market (2018-2023)
7.4.5 Merck?Company Key News & Latest Developments
7.5 Medtronic
7.5.1 Medtronic Company Summary
7.5.2 Medtronic Business Overview
7.5.3 Medtronic Diabetes Treatment Major Product Offerings
7.5.4 Medtronic Diabetes Treatment Revenue in Global Market (2018-2023)
7.5.5 Medtronic Key News & Latest Developments
7.6 Johnson?Johnson
7.6.1 Johnson?Johnson Company Summary
7.6.2 Johnson?Johnson Business Overview
7.6.3 Johnson?Johnson Diabetes Treatment Major Product Offerings
7.6.4 Johnson?Johnson Diabetes Treatment Revenue in Global Market (2018-2023)
7.6.5 Johnson?Johnson Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Diabetes Treatment Major Product Offerings
7.7.4 Sanofi Diabetes Treatment Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Diabetes Treatment Major Product Offerings
7.8.4 GlaxoSmithKline Diabetes Treatment Revenue in Global Market (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Company Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Diabetes Treatment Major Product Offerings
7.9.4 Abbott Laboratories Diabetes Treatment Revenue in Global Market (2018-2023)
7.9.5 Abbott Laboratories Key News & Latest Developments
7.10 Benemae
7.10.1 Benemae Company Summary
7.10.2 Benemae Business Overview
7.10.3 Benemae Diabetes Treatment Major Product Offerings
7.10.4 Benemae Diabetes Treatment Revenue in Global Market (2018-2023)
7.10.5 Benemae Key News & Latest Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Company Summary
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly Diabetes Treatment Major Product Offerings
7.11.4 Eli Lilly Diabetes Treatment Revenue in Global Market (2018-2023)
7.11.5 Eli Lilly Key News & Latest Developments
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Company Summary
7.12.2 Boehringer Ingelheim Business Overview
7.12.3 Boehringer Ingelheim Diabetes Treatment Major Product Offerings
7.12.4 Boehringer Ingelheim Diabetes Treatment Revenue in Global Market (2018-2023)
7.12.5 Boehringer Ingelheim Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetes Treatment Market Opportunities & Trends in Global Market
Table 2. Diabetes Treatment Market Drivers in Global Market
Table 3. Diabetes Treatment Market Restraints in Global Market
Table 4. Key Players of Diabetes Treatment in Global Market
Table 5. Top Diabetes Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diabetes Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diabetes Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diabetes Treatment Product Type
Table 9. List of Global Tier 1 Diabetes Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diabetes Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Diabetes Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diabetes Treatment Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Diabetes Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Diabetes Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diabetes Treatment Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Diabetes Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Diabetes Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diabetes Treatment Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Diabetes Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diabetes Treatment Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Diabetes Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diabetes Treatment Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Diabetes Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diabetes Treatment Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Diabetes Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diabetes Treatment Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Diabetes Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diabetes Treatment Revenue, (US$, Mn), 2024-2030
Table 30. Novo Nordisk Company Summary
Table 31. Novo Nordisk Diabetes Treatment Product Offerings
Table 32. Novo Nordisk Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Novo Nordisk Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Diabetes Treatment Product Offerings
Table 36. AstraZeneca Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Teva Pharmaceuticals Company Summary
Table 39. Teva Pharmaceuticals Diabetes Treatment Product Offerings
Table 40. Teva Pharmaceuticals Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Teva Pharmaceuticals Key News & Latest Developments
Table 42. Merck?Company Company Summary
Table 43. Merck?Company Diabetes Treatment Product Offerings
Table 44. Merck?Company Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Merck?Company Key News & Latest Developments
Table 46. Medtronic Company Summary
Table 47. Medtronic Diabetes Treatment Product Offerings
Table 48. Medtronic Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Medtronic Key News & Latest Developments
Table 50. Johnson?Johnson Company Summary
Table 51. Johnson?Johnson Diabetes Treatment Product Offerings
Table 52. Johnson?Johnson Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson?Johnson Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Diabetes Treatment Product Offerings
Table 56. Sanofi Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Diabetes Treatment Product Offerings
Table 60. GlaxoSmithKline Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Abbott Laboratories Company Summary
Table 63. Abbott Laboratories Diabetes Treatment Product Offerings
Table 64. Abbott Laboratories Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Abbott Laboratories Key News & Latest Developments
Table 66. Benemae Company Summary
Table 67. Benemae Diabetes Treatment Product Offerings
Table 68. Benemae Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Benemae Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly Diabetes Treatment Product Offerings
Table 72. Eli Lilly Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Eli Lilly Key News & Latest Developments
Table 74. Boehringer Ingelheim Company Summary
Table 75. Boehringer Ingelheim Diabetes Treatment Product Offerings
Table 76. Boehringer Ingelheim Diabetes Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Boehringer Ingelheim Key News & Latest Developments
List of Figures
Figure 1. Diabetes Treatment Segment by Type in 2022
Figure 2. Diabetes Treatment Segment by Application in 2022
Figure 3. Global Diabetes Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetes Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Diabetes Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Treatment Revenue in 2022
Figure 8. By Type - Global Diabetes Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Diabetes Treatment Revenue Market Share, 2018-2030
Figure 10. By Type - Global Diabetes Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Diabetes Treatment Revenue Market Share, 2018-2030
Figure 12. By Application - Global Diabetes Treatment Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Diabetes Treatment Revenue Market Share, 2018-2030
Figure 14. By Region - Global Diabetes Treatment Revenue Market Share, 2018-2030
Figure 15. By Country - North America Diabetes Treatment Revenue Market Share, 2018-2030
Figure 16. US Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Diabetes Treatment Revenue Market Share, 2018-2030
Figure 20. Germany Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. France Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Diabetes Treatment Revenue Market Share, 2018-2030
Figure 28. China Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. India Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Diabetes Treatment Revenue Market Share, 2018-2030
Figure 34. Brazil Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Diabetes Treatment Revenue Market Share, 2018-2030
Figure 37. Turkey Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Diabetes Treatment Revenue, (US$, Mn), 2018-2030
Figure 41. Novo Nordisk Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva Pharmaceuticals Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck?Company Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Medtronic Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson?Johnson Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GlaxoSmithKline Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Abbott Laboratories Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Benemae Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Eli Lilly Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Boehringer Ingelheim Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
